Category: News

Investors are known for their interest in future tech and their appreciation of fine art – but would the love remain if these areas were combined? One enterprising CEO may have the answer.

Just over a week after the Indonesian Government granted its approval in a milestone decision, the first-ever drill rig to enter Woyla has been fired up and drilling has begun at the highly prospective copper-gold project.

The Australian pharma landscape is in for a notable change with the down-scheduling of low-dose cannabidiol (CBD) products to Schedule 3 (S3) or ‘pharmacist only medicine’ – and one health and wellness innovator’s proven capability to take brands to market ‘first and fast’ puts it in a unique position to be a pioneer in the industry.

There’s about a 50-50 chance you’ll get cancer at some point. Already the world’s second leading cause of death and of years of life lost, the global cancer burden is expected to grow 47% between 2020 and 2040, to about 29 million cases annually.

Every second week we invite a leading fund manager to present at The Insider: Meet the Fund Manager. In April, Yarra Capital Management’s Joel Fleming selected Calidus Resources as one of his favourite stocks, noting its potential for strong cash…

A fast-growing Australian health and wellness company is eyeing a big piece of a very big pie that is getting close to being baked: Australia’s over-the-counter medicinal cannabis S3 market.

Australia is a little safer than it was in FY22 with ASX-listed Spectur this week announcing wins in beach safety, new tech ready for market, and a record start to revenue and sales in FY23.

As young, tech-savvy buyers gain market share, digitised and personalised services are becoming the norm. These consumers like to manage their lives from their phones, and they expect curated customer journeys to be available to them 24/7.

The domestic market opened down more than 2.5% from last night’s close, before clawing back initial losses to be down 2.37% by mid afternoon. The Australian dollar followed suit, down 2.26% to near 52-week lows.

Where global mining giants Barrick Gold (A$39 billion) and Newcrest (A$15 billion) stumbled and fell, a comparative minnow has hit the ground running – making history in the process.

The manager of our National Electricity Market has warned that we will soon start running short of power generation and transmission capacity, risking blackouts, unless we act fast.

ASX-listed biotech Prescient Therapeutics is crossing a major inflection point on the back of three milestone announcements made within a span of less than eight weeks – including one today.